retatrutide vs semaglutide vs tirzepatide Retatrutide: 2026 Chicago Guide Retatrutide vs Tirzepatide vs Semaglutide

Wegovys patent relies on semaglutides secondary patents, possibly lasting to 2033, so no generic is expected for at least five years

Red flags requiring immediate evaluation include severe abdominal pain (possible pancreatitis), persistent vomiting leading to dehydration, suicidal thoughts, development of new eating disorder behaviors, syncope, chest pain, hematemesis/melena, severe constipation/obstipation, orthostatic hypotension, or marked electrolyte abnormalities

Summary: Retatrutide doses are measured in milligrams (mg), not 'units'

If you have severe symptoms or think youre having an emergency, call 911 or seek emergency care

*nutrient reference values

A thorough assessment by qualified professionals is essential